The Only Quantitative ELISA Made with Stellar KLH™
Stellar Biotechnologies offers a broad suite of Anti-KLH ELISA Test Kits, available to measure either IgG or IgM, in non-human primate, mouse and rat models.
|ELI-01G||Mouse Anti-KLH IgG ELISA Kit|
|ELI-01M||Mouse Anti-KLH IgM ELISA Kit|
|ELI-02G||Rat Anti-KLH IgG ELISA Kit|
|ELI-02M||Rat Anti-KLH IgM ELISA Kit|
|ELI-03G||NHP Anti-KLH IgG ELISA Kit|
|ELI-03M||NHP Anti-KLH IgM ELISA Kit|
Use together with Stellar KLH™ Protein as the immune stimulant to ensure the highest level of control over variability.
Advantages of Stellar KLH™ ELISA Test Kits
The quality of KLH used for solid phase (microtiter well) immobilization can affect ELISA test results. Only Stellar brand assay plates are pre-coated with proprietary Stellar KLH™ formulation which provides wide dynamic range, low assay background noise and quantitative measurement.
- Quantitative ELISA
- Wide Dynamic Range
- Low Assay Background
- Reproducible Linearity
- Validated with Controls
- Consistent Results
Principle of The Anti-KLH ELISA Test
In drug screening applications, determination of a drug candidate's immunosuppressive effects on anti-KLH antibody levels allows easy assessment of immune system regulation. Animals are immunized with KLH while undergoing drug treatment and serum is collected at appropriate times post-immunization. Typically, serum collected 5-7 days after immunization is used for measurement of anti-KLH IgM levels, and serum collected 14+ days post immunization is used to measure anti-KLH IgG levels. Comparison of anti-KLH IgM or IgG levels in drug-treated vs. control groups reveals effects on immune response.
Only Stellar KLH™ ELISA Test Kits are made using Stellar KLH™ protein and are designed for rapid and quantitative measurement of anti-KLH IgG and IgM levels in serum or plasma.
KLH is well known as a potent stimulator of humoral and cellular immune responses. It is widely used in research and clinical studies as an antigen for assessing immune function or in the screening of drug candidates.